General Equity Holdings LP - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 156 filers reported holding CARDLYTICS INC in Q4 2019. The put-call ratio across all filers is 1.85 and the average weighting 0.7%.

Quarter-by-quarter ownership
General Equity Holdings LP ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$7,857,548
+145.6%
476,215
-5.9%
9.59%
+102.4%
Q2 2023$3,199,791
-37.5%
506,296
-66.4%
4.74%
-60.7%
Q1 2023$5,123,014
+0.7%
1,508,988
+71.5%
12.06%
-3.9%
Q4 2022$5,086,868
-16.0%
880,081
+36.7%
12.54%
+33.0%
Q3 2022$6,053,000
+85.8%
643,906
+562.5%
9.43%
+262.9%
Q3 2019$3,258,00097,2002.60%
Other shareholders
CARDLYTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
CAS Investment Partners, LLC 5,416,116$89,365,91411.46%
KPS Global Asset Management UK Ltd 1,218,830$20,110,69510.97%
WORLDLY PARTNERS MANAGEMENT, LLC 996,881$16,448,53710.50%
General Equity Holdings LP 476,215$7,857,5489.59%
BERYLSON CAPITAL PARTNERS, LLC 195,000$3,217,5008.24%
BRIGHTLIGHT CAPITAL MANAGEMENT LP 454,769$7,503,6895.27%
PB INVESTMENT PARTNERS, L.P. 343,061$5,660,5064.83%
VISA INC. 134,914$2,226,0812.50%
683 Capital Management, LLC 1,760,070$29,041,1562.26%
Antipodean Advisors LLC 20,000$330,0001.69%
View complete list of CARDLYTICS INC shareholders